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Background: One in three young people use cannabis in Canada. Cannabis use can be associated with a variety of
health problems which occur primarily among intensive/frequent users. Availability and effectiveness of
conventional treatment for cannabis use is limited. While Brief Interventions (BIs) have been shown to result in
short-term reductions of cannabis use risks or problems, few studies have assessed their longer-term effects. The
present study examined 12-month follow-up outcomes for BIs in a cohort of young Canadian high-frequency
cannabis users where select short-term effects (3 months) had previously been assessed and demonstrated.
Findings: N=134 frequent cannabis users were recruited from among university students in Toronto, randomized to
either an oral or a written cannabis BI, or corresponding health controls, and assessed in-person at baseline, 3-months,
and 12-months. N= 72 (54 %) of the original sample were retained for follow-up analyses at 12-months where
reductions in ‘deep inhalation/breathholding’ (Q= 13.1; p< .05) and ‘driving after cannabis use’ (Q= 9.3; p< .05) were
observed in the experimental groups. Reductions for these indicators had been shown at 3-months in the experimental
groups; these reductions were maintained over the year. Other indicators assessed remained overall stable in both
experimental and control groups.
Conclusions: The results confirm findings from select other studies indicating the potential for longer-term and
sustained risk reduction effects of BIs for cannabis use. While further research is needed on the long-term effects of BIs,
these may be a valuable – and efficient – intervention tool in a public health approach to high-risk cannabis use.
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Cannabis use is prevalent in Canada; about one in ten
adults are current users [1,2]. Use is disproportionately
prevalent among young people (e.g., 15 – 24 years of age)
including secondary and post-secondary students, where
some 25 % - 36 % are current cannabis users [1,3]. A var-
iety of health risks – including cognitive and psychomotor
impairment, bronchial or pulmonary problems, mental
health and dependence, injuries - are associated with can-
nabis use [4,5]. However, these problems disproportion-
ately occur in a minority of users [6,7]. More specifically,* Correspondence: bfischer@sfu.ca
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reproduction in any medium, provided the orintensive (e.g., frequent/daily) users are at high risk for
above problems and hence form a primary target group
for interventions [6,8,9].
Traditional treatment interventions are limited in
availability and effectiveness. In this context, the utility
of so-called ‘Brief Interventions’ (BIs) for reducing risk
or problem outcomes from cannabis use has recently
been examined. BIs are largely modelled after similar
efforts in other substance use areas, mainly alcohol,
where reductions in risk behaviors have been shown
[10-12]. BIs for cannabis use usually consist of a small
number of intervention units, delivered in varying for-
mats, conveying information and/or motivational com-
ponents towards reducing risk behaviors or problems
[13,14]. BIs for cannabis use have been shown to achieve
substantive short-term reductions in, for example, can-
nabis use frequency or problem indicators (e.g.,Ltd This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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longer-term effects is limited [15,16].
The objective of this present study was to assess the
longer-term (i.e., 12-months) impact of a customized BI
module for cannabis use on select risk outcome indicators,
for which short-term (i.e., 3-months) impact was previ-
ously assessed and demonstrated, in frequent cannabis
users among university students in a Canadian setting.
Methods
Sample and recruitment
Details of the study methods are provided in [17]. Briefly,
participants were recruited from university student
populations in Toronto by way of mass-advertising (i.e.,
posters on campuses) based on the following eligibility
criteria: 18 – 28 years of age; full-time university enrol-
ment; cannabis use> one year; cannabis use on at least
12 of the past 30 days. Study eligibility confirmation oc-
curred by telephone, after which candidates were invited
for the in-person and anonymous study appointment.
Assessment and interventions
Baseline assessments consisted of a short (25–30 minutes)
interviewer-administered questionnaire after which partici-
pants were randomized to one of four BI groups: a cannabis
(experimental) intervention delivered either orally (C-O) or
in the form of written material (C-W), or a general health
(control) intervention delivered orally (H-O) or via written
material (H-W). The cannabis interventions consisted of
short information elements on cannabis-related health
risks, concrete suggestions for risk modification, and brief
motivational components; the main aims of the BI were to
inform users about key modifiable health risks related to
use, and to suggest tangible ways to reduce these risks with-
out principally focusing on or requiring abstinence. The
control interventions were similarly structured and
included general health information content (e.g., nutrition,
stress, exercise). The oral BIs were delivered by a health
psychologist in a 15 – 20 minutes long session; the written
BIs were provided by a 10-page booklet with corresponding
content. Follow-up assessments were conducted in-person
at 3-months (FU3) and 12-months (FU12) following the BI,
consisting of an abbreviated version of the baseline
interview.
Participants provided informed consent for all study
elements, and received small honoraria for baseline ($25)
and follow-up assessments ($30 each). The study was
approved by the investigators’ institutional research eth-
ics board.
Measures and analyses
Four measures (all ‘in the past 30 days’) collected at
baseline and follow-up assessments were used to assess
changes in key outcomes:(1)Number of cannabis use days (continuous).
(2)Average number of cannabis use episodes per use
day (continuous).
(3)Use of deep inhalation/breathholding techniques
(yes/no).
(4)Driving a vehicle within 2 hours of use (yes/no).
The FU3 analysis found little difference between the
oral and written BI modules, and thus the respective
experimental and control groups were collapsed (i.e.,
C-O+C-W and H-O+H-W) for analyses. On this
basis, the two continuous measures were analysed by a
2 (intervention group [cannabis or health]) by 3 (meas-
urement period [baseline, FU3, FU12]) ANOVA with
repeated measures over period. To account for the
correlated nature of the repeated measures the two
categorical measures were examined using Cochran’s Q
test (for changes over the 3 periods) and the more
detailed comparisons between baseline and FU3, and
FU3 and FU12 by McNemar’s chi-square.
Findings
Study sample
The baseline sample consisted of n = 134 subjects. Of
these, n = 113 (84 %) were reassessed at FU3, and n= 76
(57 %) were reassessed at FU12. Four subjects of the
FU12 sample had not attended the FU3 assessment,
meaning complete data for all three assessments resulted
in an analysis (completer) sample of n = 72 (54 %). Table 1
presents data on key socio-demographic characteristics
(e.g., age, sex, years of university enrolment) and years of
cannabis use for the baseline and completer samples and
those lost to follow up (LTF). No differences were found
for the above indicators between the completer and the
LTF samples.
Outcomes
The repeated measures ANOVAs found no statistically
significant main or interaction effects for ‘cannabis use
days’ or the ‘cannabis use episodes’. A change was
observed for ‘deep inhalation/breathholding’ over the
year for the experimental (Q= 13.1; p< .05) but not the
control (Q= 4.8; ns) group. Similarly, a change was
observed for ‘driving after cannabis use’ for the experi-
mental (Q= 9.3; p< .05) but not the control (Q= 0.9; ns)
group. Changes observed occurred in the desired direc-
tion, i.e., reductions in risk behaviours. The most sub-
stantive changes for these variables had materialized
between baseline and FU3; these effects were maintained
at the FU12 assessments. Also, for the ‘driving after
cannabis use’ variable, randomization appears to have
resulted in a higher proportion in the experimental
group at baseline reporting “Yes”; however this dropped
to the level of the control group by FU3 and this effect
was maintained over the year (see Table 2).




Age Years of University Years of Cannabis Use Sex
N Mean (sd) Mean (sd) Mean (sd) %Male
Baseline Sample All 134 20.4 (2.4) 2.5 (1.6) 5.5 (2.7) 67.2 %
Cannabis BI 72 20.3 (2.4) 2.4 (1.7) 5.5 (2.8) 65.3 %
Health BI 62 20.6 (2.5) 2.6 (1.5) 5.6 (2.6) 69.4 %
Completer (baseline, FU-3 and FU-12) Sample All 72 20.3 (2.2) 2.5 (1.4) 5.7 (2.8) 68.1 %
Cannabis BI 40 20.1 (2.1) 2.3 (1.5) 5.9 (3.0) 67.5 %
Health BI 32 20.6 (2.3) 2.7 (1.3) 5.5 (2.6) 68.8 %
Lost-to-Follow-up Sample All 62 20.6 (2.7) 2.5 (1.7) 5.3 (2.6) 66.1 %
Cannabis BI 32 20.5 (2.7) 2.6 (1.8) 5.0 (2.4) 62.5 %
Health BI 30 20.6 (2.7) 2.5 (1.6) 5.7 (2.7) 70.0 %
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outcome variables at baseline between the experimental
and control samples or between the completer and LTF
samples.
Discussion
Our results suggest that reductions in two of four key
risk outcome indicators following a BI delivered to high-
frequency young cannabis users observed at FU3 (i.e.,
deep inhalation/breathholding and driving after cannabis
use) were maintained at FU12. These results are, in
principle, consistent with findings from the (few) other
studies on longer term effects of BIs, suggesting that
reductions in specific risk behaviors from cannabis BIs
may be sustained beyond short-term periods. For ex-
ample, Dennis et al. [18] found substantial increases in the
number of abstinence days following several BIs for ado-
lescent cannabis use maintained after one year; Stephens
et al. [16] and Babor et al. [19] found post-BI reductions in
cannabis use days and problem symptoms maintained for
at least one year. Notably, our study did not see changes inTable 2 Key study outcomes among completer sample, by int
and 12-month follow-up (FU12)
Measure Group N
Number of days cannabis used Cannabis 40
Health 32
Number of cannabis use episodes/day Cannabis 40
Health 32
N
Deep inhalation/ breathholding Cannabis* 40
Health 32
Driving after cannabis use Cannabis* 40
Health 32
* Significant change over periods (p< .05).cannabis use frequency or intensity itself, as witnessed by
the above studies, but reductions were limited to the (ra-
ther specific) risk behavior variables. It needs further inves-
tigation to which extent this may be a function of the
specific BI content applied, or possibly related to partici-
pants’ dispositions that frequent cannabis use itself is not a
behavior worthy of change.
While relevant impacts from BIs appear to materialize
immediately following the interventions, the present
longer-term outcomes may be viewed as an indication of
the stability of such effects. On this basis, our results add
to the growing evidence that BIs may be a potentially ef-
fective – and efficient - tool in decreasing key cannabis
related risk behaviours relevant for individual and public
health [10,12,20]. Specifically, deep inhalation/breathhold-
ing may increase the risk for pulmonary/bronchial pro-
blems, and driving after cannabis use is likely to result in
impaired driving, associated with elevated risk for motor
vehicle accident involvement and/or injury [4,9,21,22].
While the demonstrated reductions are limited to select
indicators, and do not eliminate the specified riskervention group, at baseline, 3-month follow-up (FU3)
Mean (95 % CI)
Baseline FU 3 FU 12
24.0 (22.2-25.8) 23.1 (20.7-25.5) 22.3 (19.8-24.8)
23.9 (21.8-26.0) 23.1 (20.6-25.5) 22.1 (18.9-25.3)
2.3 (1.7-2.9) 2.4 (1.8-3.0) 2.6 (1.6-3.7)
2.0 (1.7-2.3) 2.4 (1.5-3.4) 2.2 (1.7-2.6)
Proportion Responding YES
Baseline FU 3 FU 12
78 % 52 % 57 %
81 % 78 % 68 %
44 % 31 % 24 %
30 % 27 % 24 %
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treatment interventions do not appear to result in substan-
tially more efficacious impacts [10,12].
The sustained impact and intervention utility of BIs be-
yond just ‘strawfire’ effects may further be amplified – or
extended to other behaviors - by way of implementing tar-
geted ‘booster’ interventions, e.g., by way of follow-up
calls, text messages, etc. [18,23]. Given their relative ease
and flexibility in delivery, BIs can relatively easily be
offered to high-risk groups in their natural environments
or settings (e.g., universities) [20,24,25]
The results of the present study should be further tested
in larger-scale studies examining different BI content and
delivery method options with sufficient power and longer-
term follow-ups, as well as ideally relying on an intent-to-
treat (rather than a completers_) analysis approach. Key
limitations of the present study include its small sample
size, reducing the sensitivity of our methods to detect po-
tential effects. Specifically, the health controls seemed to
indicate trends towards reductions in the risk factors
under discussion that may have evolved to significance
given more analytical power. In addition, there may have
been un-measured extrinsic factors over the study period
influencing participants’ risk behaviors that could not be
accounted for in the analysis. The study had a relatively
substantial loss to follow up – largely due to high mobility
in student cohorts – which could lead to selection biases,
although we found no relevant differences between the
analysis and LTF samples. The study relied primarily on
self-reported data, the validity of which can be confounded
(e.g., social desirability effects). The results of the study
may not be generalizable to other cannabis user
populations.
Overall, our study suggests the potential utility of BIs as
an intervention tool in Canada where cannabis use is
prevalent among young people, and BIs have largely been
ignored in the substance use arena to date. In the context
of increasing advocacy for public health oriented cannabis
use policy in Canada, BIs may further be developed and
utilized as a valuable intervention tool, primarily for sec-
ondary prevention purposes, for key risk populations
[4,20]. At this point, the vast majority of intervention
resources for cannabis use control in Canada are expended
for criminalization (e.g., arrests of users); in addition,
large-scale abstinence education or promotion campaigns
are implemented with questionable impact. A small pro-
portion of the resources used for the aforementioned pro-
grams would allow broad-based BI programs to be
implemented for high-risk cannabis users in settings (e.g.,
universities, colleges) where such populations are dispro-
portionately present and offer themselves well for such
measures, as has been shown for other public health
oriented intervention campaigns (e.g., sexual health educa-
tion or nutritional education, etc.). In addition, other keystakeholders – e.g., non-governmental public health asso-
ciations – could become involved in offering such BI
programming.
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